The human umbilical cord stem cells improve the viability of OA degenerated chondrocytes

Wang,Hao; Yan,Xu; Jiang,Yuxin; Wang,Zheng; Li,Yufei; Shao,Qingdong

doi:10.3892/mmr.2018.8413

The human umbilical cord stem cells improve the viability of OA degenerated chondrocytes

Authors:
- Hao Wang
- Xu Yan
- Yuxin Jiang
- Zheng Wang
- Yufei Li
- Qingdong Shao
View Affiliations

Affiliations: Teaching Center of Experimental Medicine, Shanghai Medical College, Fudan University, Shanghai 200032, P.R. China, Department of Orthopedics, 455th Hospital of PLA, Shanghai 200052, P.R. China, School of Medicine, Dalian Medical University, Dalian, Liaoning 116044, P.R. China, Department of Plastic Surgery, 455th Hospital of PLA, Shanghai 200052, P.R. China
Published online on: January 9, 2018 https://doi.org/10.3892/mmr.2018.8413
Pages: 4474-4482
Copyright: © Wang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Osteoarthritis (OA) affects a large number of patients; however, human umbilical cord stem cells exhibit therapeutic potential for treating OA. The aim of the present study was to explore the interaction between human umbilical cord stem cells and degenerated chondrocytes, and the therapeutic potential of human umbilical cord stem cells on degenerated chondrocytes. Human umbilical cord‑derived mesenchymal stem cells (hUC‑MSCs) were harvested from human umbilical cords, and flow cytometry was used to analyze the surface antigen markers, in addition, chondrogenic, osteogenic and adipogenic differentiation on the cells was investigated. OA cells at P3 were cocultured with hUC‑MSCs in a separated co‑culture system, and reverse transcription‑polymerase chain reaction and western blot were used to evaluate the mRNA, and protein expression of collagen type II (Col2), SRY‑box 9 (sox‑9) and aggrecan. The level of inflammatory cytokines, tumor necrosis factor‑α, interleukin (IL)‑1β, IL‑6, IL‑10, were analyzed by ELISA in the supernatant. hUC‑MSCs grow in a fibroblastic shape with stable proliferation. hUC‑MSCs expressed cluster of differentiation 44 (CD44), CD73, CD90, CD105; while did not express CD34, CD45, CD106, CD133. After multi‑induction, hUC‑MSCs were able to differatiate into adipogenic, osteogenic and chondrogenic lineage. hUC‑MSCs inhibited the expression of matrix metalloproteinase‑13, collagen type X α1 chain and cyclooxygenase‑2 in OA chondrocytes, and enhanced the proliferation of OA chondrocytes, while OA chondrocytes stimulated the production of Col2, sox‑9 and aggrecan and promoted hUC‑MSCs differentiate into chondrocytes. Flow cytometry analysis demonstrated hUC‑MSCs have a predominant expression of stem cell markers, while the hematopoietic and endothelial markers were absent. Osteogenic, chondrogenic and adipogenic differentiation was observed in certain induction conditions. hUC‑MSCs improved the proliferation of OA chondrocytes and downregulated the expression of inflammatory cytokines, while OA chondrocytes promoted MSCs to differentiate into chondrocytes. Taken together, the co‑culture of hUC‑MSCs and OA chondrocytes may provide a therapeutic potential in OA treatment.

View Figures

View References

1	Fransen M, Bridgett L, March L, Hoy D, Penserga E and Brooks P: The epidemiology of osteoarthritis in Asia. Int J Rheum Dis. 14:113–121. 2011. View Article : Google Scholar : PubMed/NCBI
2	van der Kraan PM and van den Berg WB: Chondrocyte hypertrophy and osteoarthritis: Role in initiation and progression of cartilage degeneration? Osteoarthritis Cartilage. 20:223–232. 2012. View Article : Google Scholar : PubMed/NCBI
3	Zhang Y and Jordan JM: Epidemiology of osteoarthritis. Clin Geriatr Med. 26:355–369. 2010. View Article : Google Scholar : PubMed/NCBI
4	Neogi T and Zhang Y: Epidemiology of osteoarthritis. Rheum Dis Clin North Am. 39:1–19. 2013. View Article : Google Scholar : PubMed/NCBI
5	Cross M, Smith E, Hoy D, Nolte S, Ackerman I, Fransen M, Bridgett L, Williams S, Guillemin F, Hill CL, et al: The global burden of hip and knee osteoarthritis: Estimates from the global burden of disease 2010 study. Ann Rheum Dis. 73:1323–1330. 2014. View Article : Google Scholar : PubMed/NCBI
6	Akkiraju H and Nohe A: Role of chondrocytes in cartilage formation, progression of osteoarthritis and cartilage regeneration. J Dev Biol. 3:177–192. 2015. View Article : Google Scholar : PubMed/NCBI
7	Dreier R: Hypertrophic differentiation of chondrocytes in osteoarthritis: The developmental aspect of degenerative joint disorders. Arthritis Res Ther. 12:2162010. View Article : Google Scholar : PubMed/NCBI
8	Mobasheri A, Kalamegam G, Musumeci G and Batt ME: Chondrocyte and mesenchymal stem cell-based therapies for cartilage repair in osteoarthritis and related orthopaedic conditions. Maturitas. 78:188–198. 2014. View Article : Google Scholar : PubMed/NCBI
9	Bennell KL, Hunter DJ and Hinman RS: Management of osteoarthritis of the knee. BMJ. 345:e49342012. View Article : Google Scholar : PubMed/NCBI
10	Jakob R: The management of early osteoarthritis. Knee. 21:799–800. 2014. View Article : Google Scholar : PubMed/NCBI
11	Kon E, Filardo G, Drobnic M, Madry H, Jelic M, van Dijk N and Della Villa S: Non-surgical management of early knee osteoarthritis. Knee Surg Sports Traumatol Arthrosc. 20:436–449. 2012. View Article : Google Scholar : PubMed/NCBI
12	Musumeci G, Loreto C, Castorina S, Imbesi R, Leonardi R and Castrogiovanni P: Current concepts in the treatment of cartilage damage. A review. Ital J Anat Embryol. 118:189–203. 2013.PubMed/NCBI
13	Musumeci G, Mobasheri A, Trovato FM, Szychlinska MA, Graziano AC, Lo Furno D, Avola R, Mangano S, Giuffrida R and Cardile V: Biosynthesis of collagen I, II, RUNX2 and lubricin at different time points of chondrogenic differentiation in a 3D in vitro model of human mesenchymal stem cells derived from adipose tissue. Acta Histochem. 116:1407–1417. 2014. View Article : Google Scholar : PubMed/NCBI
14	Musumeci G, Castrogiovanni P, Leonardi R, Trovato FM, Szychlinska MA, Di Giunta A, Loreto C and Castorina S: New perspectives for articular cartilage repair treatment through tissue engineering: A contemporary review. World J Orthop. 5:80–88. 2014. View Article : Google Scholar : PubMed/NCBI
15	Szychlinska MA, Stoddart MJ, D'Amora U, Ambrosio L, Alini M PhD and Musumeci G: Mesenchymal stem cell-based cartilage regeneration approach and cell senescence: Can we manipulate cell aging and function? Tissue Eng Part B Rev. May 17–2017.(Epub ahead of print). View Article : Google Scholar : PubMed/NCBI
16	Savkovic V, Li H, Seon JK, Hacker M, Franz S and Simon JC: Mesenchymal stem cells in cartilage regeneration. Curr Stem Cell Res Ther. 9:469–488. 2014. View Article : Google Scholar : PubMed/NCBI
17	Pers YM, Ruiz M, Noël D and Jorgensen C: Mesenchymal stem cells for the management of inflammation in osteoarthritis: State of the art and perspectives. Osteoarthritis Cartilage. 23:2027–2035. 2015. View Article : Google Scholar : PubMed/NCBI
18	Musumeci G, Lo Furno D, Loreto C, Giuffrida R, Caggia S, Leonardi R and Cardile V: Mesenchymal stem cells from adipose tissue which have been differentiated into chondrocytes in three-dimensional culture express lubricin. Exp Biol Med (Maywood). 236:1333–1341. 2011. View Article : Google Scholar : PubMed/NCBI
19	Szychlinska MA, Castrogiovanni P, Nsir H, Di Rosa M, Guglielmino C, Parenti R, Calabrese G, Pricoco E, Salvatorelli L, Magro G, et al: Engineered cartilage regeneration from adipose tissue derived-mesenchymal stem cells: A morphomolecular study on osteoblast, chondrocyte and apoptosis evaluation. Exp Cell Res. 357:222–235. 2017. View Article : Google Scholar : PubMed/NCBI
20	Ding DC, Chang YH, Shyu WC and Lin SZ: Human umbilical cord mesenchymal stem cells: A new era for stem cell therapy. Cell Transplant. 24:339–347. 2015. View Article : Google Scholar : PubMed/NCBI
21	Gauthaman K, Yee FC, Cheyyatraivendran S, Biswas A, Choolani M and Bongso A: Human umbilical cord Wharton's jelly stem cell (hWJSC) extracts inhibit cancer cell growth in vitro. J Cell Biochem. 113:2027–2039. 2012. View Article : Google Scholar : PubMed/NCBI
22	Ali H, Al-Yatama MK, Abu-Farha M, Behbehani K and Al Madhoun A: Multi-lineage differentiation of human umbilical cord Wharton's Jelly Mesenchymal Stromal Cells mediates changes in the expression profile of stemness markers. PLoS One. 10:e01224652015. View Article : Google Scholar : PubMed/NCBI
23	Fernandes AM, Herlofsen SR, Karlsen TA, Küchler AM, Fløisand Y and Brinchmann JE: Similar properties of chondrocytes from osteoarthritis joints and mesenchymal stem cells from healthy donors for tissue engineering of articular cartilage. PLoS One. 8:e629942013. View Article : Google Scholar : PubMed/NCBI
24	Wang ZH, Li XL, He XJ, Wu BJ, Xu M, Chang HM, Zhang XH, Xing Z, Jing XH, Kong DM, et al: Delivery of the Sox9 gene promotes chondrogenic differentiation of human umbilical cord blood-derived mesenchymal stem cells in an in vitro model. Braz J Med Biol Res. 47:279–286. 2014. View Article : Google Scholar : PubMed/NCBI
25	Hata K, Watanabe Y, Nakai H, Hata T and Hoshiai H: Expression of the vascular endothelial growth factor (VEGF) gene in epithelial ovarian cancer: An approach to anti-VEGF therapy. Anticancer Res. 31:731–737. 2011.PubMed/NCBI
26	Puljak L, Marin A, Vrdoljak D, Markotic F, Utrobicic A and Tugwell P: Celecoxib for osteoarthritis. Cochrane Database Syst Rev. 5:CD0098652017.PubMed/NCBI
27	Xu Q, Chen B, Wang Y, Wang X, Han D, Ding D, Zheng Y, Cao Y, Zhan H and Zhou Y: The effectiveness of manual therapy for relieving pain, stiffness, and dysfunction in knee osteoarthritis: A systematic review and meta-analysis. Pain Physician. 20:229–243. 2017.PubMed/NCBI
28	Fellows CR, Matta C, Zakany R, Khan IM and Mobasheri A: Adipose, bone marrow and synovial joint-derived mesenchymal stem cells for cartilage repair. Front Genet. 7:2132016. View Article : Google Scholar : PubMed/NCBI
29	Chakravarthy K, Chen Y, He C and Christo PJ: Stem cell therapy for chronic pain management: Review of uses, advances, and adverse effects. Pain Physician. 20:293–305. 2017.PubMed/NCBI
30	Cui GH, Wang YY, Li CJ, Shi CH and Wang WS: Efficacy of mesenchymal stem cells in treating patients with osteoarthritis of the knee: A meta-analysis. Exp Ther Med. 12:3390–3400. 2016. View Article : Google Scholar : PubMed/NCBI
31	Kohno Y, Mizuno M, Ozeki N, Katano H, Komori K, Fujii S, Otabe K, Horie M, Koga H, Tsuji K, et al: Yields and chondrogenic potential of primary synovial mesenchymal stem cells are comparable between rheumatoid arthritis and osteoarthritis patients. Stem Cell Res Ther. 8:1152017. View Article : Google Scholar : PubMed/NCBI
32	Feng C, Luo X, He N, Xia H, Lv X, Zhang X, Li D, Wang F, He J, Zhang L, et al: Efficacy and persistence of allogeneic adipose-derived mesenchymal stem cells combined with hyaluronic acid in osteoarthritis after intra-articular injection in a sheep model. Tissue Eng Part A. Sep 27–2017.(Epub ahead of print). PubMed/NCBI
33	Zhang Q, Chen Y, Wang Q, Fang C, Sun Y, Yuan T, Wang Y, Bao R and Zhao N: Effect of bone marrow-derived stem cells on chondrocytes from patients with osteoarthritis. Mol Med Rep. 13:1795–1800. 2016. View Article : Google Scholar : PubMed/NCBI
34	Kim SW, Han H, Chae GT, Lee SH, Bo S, Yoon JH, Lee YS, Lee KS, Park HK and Kang KS: Successful stem cell therapy using umbilical cord blood-derived multipotent stem cells for Buerger's disease and ischemic limb disease animal model. Stem Cells. 24:1620–1626. 2006. View Article : Google Scholar : PubMed/NCBI
35	Baker CD and Abman SH: Umbilical cord stem cell therapy for bronchopulmonary dysplasia: Ready for prime time? Thorax. 68:402–404. 2013. View Article : Google Scholar : PubMed/NCBI
36	Gu Z, Akiyama K, Ma X, Zhang H, Feng X, Yao G, Hou Y, Lu L, Gilkeson GS, Silver RM, et al: Transplantation of umbilical cord mesenchymal stem cells alleviates lupus nephritis in MRL/lpr mice. Lupus. 19:1502–1514. 2010. View Article : Google Scholar : PubMed/NCBI
37	Nagamura-Inoue T and He H: Umbilical cord-derived mesenchymal stem cells: Their advantages and potential clinical utility. World J Stem Cells. 6:195–202. 2014. View Article : Google Scholar : PubMed/NCBI
38	Mennan C, Brown S, McCarthy H, Mavrogonatou E, Kletsas D, Garcia J, Balain B, Richardson J and Roberts S: Mesenchymal stromal cells derived from whole human umbilical cord exhibit similar properties to those derived from Wharton's jelly and bone marrow. FEBS Open Bio. 6:1054–1066. 2016. View Article : Google Scholar : PubMed/NCBI
39	Li X, Duan L, Liang Y, Zhu W, Xiong J and Wang D: Human umbilical cord blood-derived mesenchymal stem cells contribute to chondrogenesis in coculture with chondrocytes. Biomed Res Int. 2016:38270572016.PubMed/NCBI
40	Wang J, Li J, Deng N, Zhao X, Liu Y, Wang X and Zhang H: Transfection of hBMP-2 into mesenchymal stem cells derived from human umbilical cord blood and bone marrow induces cell differentiation into chondrocytes. Minerva Med. 105:283–288. 2014.PubMed/NCBI
41	Zheng P, Ju L, Jiang B, Chen L, Dong Z, Jiang L, Wang R and Lou Y: Chondrogenic differentiation of human umbilical cord blood-derived mesenchymal stem cells by co-culture with rabbit chondrocytes. Mol Med Rep. 8:1169–1182. 2013. View Article : Google Scholar : PubMed/NCBI
42	Mennan C, Wright K, Bhattacharjee A, Balain B, Richardson J and Roberts S: Isolation and characterisation of mesenchymal stem cells from different regions of the human umbilical cord. Biomed Res Int. 2013:9161362013. View Article : Google Scholar : PubMed/NCBI
43	Wu L, Prins HJ, Helder MN, van Blitterswijk CA and Karperien M: Trophic effects of mesenchymal stem cells in chondrocyte co-cultures are independent of culture conditions and cell sources. Tissue Eng Part A. 18:1542–1551. 2012. View Article : Google Scholar : PubMed/NCBI
44	Meretoja VV, Dahlin RL, Kasper FK and Mikos AG: Enhanced chondrogenesis in co-cultures with articular chondrocytes and mesenchymal stem cells. Biomaterials. 33:6362–6369. 2012. View Article : Google Scholar : PubMed/NCBI
45	Jo CH, Lee YG, Shin WH, Kim H, Chai JW, Jeong EC, Kim JE, Shim H, Shin JS, Shin IS, et al: Intra-articular injection of mesenchymal stem cells for the treatment of osteoarthritis of the knee: A proof-of-concept clinical trial. Stem Cells. 32:1254–1266. 2014. View Article : Google Scholar : PubMed/NCBI
46	Zhu Y, Guan YM, Huang HL and Wang QS: Human umbilical cord blood mesenchymal stem cell transplantation suppresses inflammatory responses and neuronal apoptosis during early stage of focal cerebral ischemia in rabbits. Acta Pharmacol Sin. 35:585–591. 2014. View Article : Google Scholar : PubMed/NCBI
47	Min F, Gao F, Li Q and Liu Z: Therapeutic effect of human umbilical cord mesenchymal stem cells modified by angiotensin-converting enzyme 2 gene on bleomycin-induced lung fibrosis injury. Mol Med Rep. 11:2387–2396. 2015. View Article : Google Scholar : PubMed/NCBI
48	Amable PR, Teixeira MV, Carias RB, Granjeiro JM and Borojevic R: Protein synthesis and secretion in human mesenchymal cells derived from bone marrow, adipose tissue and Wharton's jelly. Stem Cell Res Ther. 5:532014. View Article : Google Scholar : PubMed/NCBI
49	Chen J, Liu Z, Hong MM, Zhang H, Chen C, Xiao M, Wang J, Yao F, Ba M, Liu J, et al: Proangiogenic compositions of microvesicles derived from human umbilical cord mesenchymal stem cells. PLoS One. 9:e1153162014. View Article : Google Scholar : PubMed/NCBI
50	Zhang B, Wang M, Gong A, Zhang X, Wu X, Zhu Y, Shi H, Wu L, Zhu W, Qian H and Xu W: HucMSC-exosome mediated-Wnt4 signaling is required for cutaneous wound healing. Stem Cells. 33:2158–2168. 2015. View Article : Google Scholar : PubMed/NCBI